This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

RNA technology has had its own Big Bang event. It occurred just a couple of years ago when, seemingly out of nothing, the mRNA-based COVID-19 vaccines appeared. Well, they only seemed to come out of ...

This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...

Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...

New solutions to previously uncontrolled pests, improved application efficicacy and climate resilience are all benefits Ryan Rapp, CEO and co-founder of Terrana Biosciences, says are possible. The ...

Researchers have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

CEATEC 2025 featured the usual lineup of AI demos, service robots, and experimental interfaces. But inside Hall 4, a quieter, lab-style booth ...

Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...

PRQR, last year, failed a pivotal trial. This is the third time it has failed trials after showing early signs of efficacy. While they are making an effort, I see little future here. PRQR is a Dutch ...

The discovery of a juvenile woolly mammoth named Yuka, found in Siberian permafrost with its skin and muscles intact, has already marked paleontological history. A team of scientists has just ...